Resistance Mechanisms to Targeted Therapeutics in Single Cells

Originally from Colorado, Jon received his undergraduate degree from the University of Colorado at Boulder in Molecular, Cellular, and Developmental Biology. He completed his doctoral work in the Department of Genetics at Duke University Medical Center and his postdoctoral training at the University of North Carolina Chapel Hill. Prior to entering the biotechnology sector, Jon was a Research Assistant Professor in the Department of Pharmacology at the UNC Chapel Hill School of Medicine with an emphasis on epigenetic adaptation to targeted therapies in breast cancer.